equityflowunderstand the flow and follow it
EquityFlowCompanies › Biofourmis

Biofourmis

Healthtech · Boston, US · biofourmis.com

Virtual care and digital therapeutics platform

Founders

Team & hubs

In the network

Shares the most investors with (number = shared investors):

Funding history

DateRoundAmount
May 2022Series D Plus
Biofourmis, a Boston-based virtual care and digital medicine company, raised a $300M Series D led by General Atlantic at a unicorn valuation, with CVS Health and SoftBank Vision Fund 2 participating.
$300M

Investors

Tap an investor to see what else they have backed.

Other companies in Healthtech

Other companies in US

Other companies at Series D Plus stage

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.